Media

Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform

San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”).  today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]

Continue reading